OriGene Technologies Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:OriGene Technologies Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014065
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
OriGene Technologies Inc (OriGene) is a research tool company that develops cDNA. The company creates commercial collection of full-length human cDNAs in expression vector. It develops, manufactures and sells genome research and diagnostic products. OriGene’s products include qPCR reagents, transfection reagent, precisionshuttling kits, cDNA clones, HuSH shRNA, plasmid purification, siRNA, miRNA, proteins antibodies, IHC products, assays and human tissues, among others. The company’s services include gene synthesis, custom shRNA, custom cloning, custom protein service, antibody service, assay development and stable cell line development. It provides research in the areas of cancer biomarker research, pathology IHC, stem cell research, ion channels, and protein kinase. The company offers products and services to pharmaceutical and biotechnology companies and academic research institutes. OriGene is headquartered in Rockville, Maryland, the US.

OriGene Technologies Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
OriGene Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
OriGene Technologies Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
OriGene Technologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
OriGene Technologies Inc, Medical Devices Deals, 2011 to YTD 2017 8
OriGene Technologies Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
OriGene Technologies Inc, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
Strategic Diagnostics Completes Sale Of Life Science Business Assets To OriGene For US$16 Million 10
Venture Financing 12
OriGene Technologies Raises Funds in Financing Round 12
OriGene Technologies Raises US$21 Million In Series C Financing 13
Origene Technologies Raises US$15 Million In Venture Financing 14
Partnerships 15
OriGene Technologies Enters into Contract with National Cancer Institute 15
Entia Biosciences Enters Into Co-Development Agreement With Biocheck 16
Licensing Agreements 17
Dako Enters into Licensing Agreement with OriGene Technologies 17
Asset Transactions 18
Strategic Diagnostics Completes Sale Of Life Science Business Assets To OriGene For US$16 Million 18
Romer Labs Completes Acquisition Of Food Safety And GMO Business Of Strategic Diagnostics For US$13.5 Million 20
Acquisition 21
OriGene Technologies Acquires Acris Antibodies 21
OriGene Technologies Inc – Key Competitors 22
OriGene Technologies Inc – Key Employees 23
OriGene Technologies Inc – Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
OriGene Technologies Inc, Pharmaceuticals & Healthcare, Key Facts 2
OriGene Technologies Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 2
OriGene Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
OriGene Technologies Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
OriGene Technologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
OriGene Technologies Inc, Medical Devices Deals, 2011 to YTD 2017 8
OriGene Technologies Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Strategic Diagnostics Completes Sale Of Life Science Business Assets To OriGene For US$16 Million 10
OriGene Technologies Raises Funds in Financing Round 12
OriGene Technologies Raises US$21 Million In Series C Financing 13
Origene Technologies Raises US$15 Million In Venture Financing 14
OriGene Technologies Enters into Contract with National Cancer Institute 15
Entia Biosciences Enters Into Co-Development Agreement With Biocheck 16
Dako Enters into Licensing Agreement with OriGene Technologies 17
Strategic Diagnostics Completes Sale Of Life Science Business Assets To OriGene For US$16 Million 18
Romer Labs Completes Acquisition Of Food Safety And GMO Business Of Strategic Diagnostics For US$13.5 Million 20
OriGene Technologies Acquires Acris Antibodies 21
OriGene Technologies Inc, Key Competitors 22
OriGene Technologies Inc, Key Employees 23
OriGene Technologies Inc, Other Locations 24
OriGene Technologies Inc, Subsidiaries 24

★海外企業調査レポート[OriGene Technologies Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • George Weston Ltd (WN):企業の財務・戦略的SWOT分析
    George Weston Ltd (WN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Airgain, Inc. (AIRG):企業の財務・戦略的SWOT分析
    Airgain, Inc. (AIRG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Landsvirkjun hf:企業の戦略的SWOT分析
    Landsvirkjun hf - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • S Group:企業の戦略的SWOT分析
    S Group - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • Lear Corporation (LEA):企業の財務・戦略的SWOT分析
    Lear Corporation (LEA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • National Bank of Kuwait S.A.K.:戦略・SWOT・企業財務分析
    National Bank of Kuwait S.A.K. - Strategy, SWOT and Corporate Finance Report Summary National Bank of Kuwait S.A.K. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • GAIL (India) Limited:企業の戦略・SWOT・財務分析
    GAIL (India) Limited - Strategy, SWOT and Corporate Finance Report Summary GAIL (India) Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • SunPower Corp (SPWR):企業の財務・戦略的SWOT分析
    SunPower Corp (SPWR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • St. James’S Place Plc
    St. James'S Place Plc - Strategy, SWOT and Corporate Finance Report Summary St. James'S Place Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Citizens Energy Group:企業の戦略的SWOT分析
    Citizens Energy Group - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Aldevron LLC-製薬・医療分野:企業M&A・提携分析
    Summary Aldevron LLC (Aldevron) is a custom manufacturing and development service provider. The company manufactures plasmid deoxyribonucleic acid for research, preclinical and clinical applications. It offers nucleic acid, protein, and antibody services. Aldevron's protein production services inclu …
  • InnaVirVax SA-製薬・医療分野:企業M&A・提携分析
    Summary InnaVirVax SA (InnaVirVax) is a biopharmaceutical company which discovers and develops products for the treatment of HIV/AIDS infection pathologically and novel cancer therapies. The company's pipeline product portfolio comprise DIAG-3S, an AIDS prognostic test; VAC-3S, an HIV AIDs therapeut …
  • Dongfang Electric Corporation Ltd (1072):企業の財務・戦略的SWOT分析
    Dongfang Electric Corporation Ltd (1072) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • KONE Corporation:企業の戦略・SWOT・財務情報
    KONE Corporation - Strategy, SWOT and Corporate Finance Report Summary KONE Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Jefferies Group LLC:企業のM&A・事業提携・投資動向
    Jefferies Group LLC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Jefferies Group LLC Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • AmerisourceBergen Corp (ABC):医療機器:M&Aディール及び事業提携情報
    Summary AmerisourceBergen Corp (AmerisourceBergen) is a pharmaceutical sourcing and distribution services company. It offers a wide range of services ranging from drug distribution to manufacturer solutions including niche premium logistics services, reimbursement and pharmaceutical consulting servi …
  • Sophiris Bio Inc (SPHS):製薬・医療:M&Aディール及び事業提携情報
    Summary Sophiris Bio Inc (Sophiris) is a clinical stage bio-pharmaceutical company, which focuses on developing products for the treatment of urological diseases. Sophiris lead drug candidate, PRX302 is under late stage development for the treatment of lower urinary tract symptoms of benign prostati …
  • Murmanskoye Morskoye Parokhodstvo:企業の戦略・SWOT・財務情報
    Murmanskoye Morskoye Parokhodstvo - Strategy, SWOT and Corporate Finance Report Summary Murmanskoye Morskoye Parokhodstvo - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • New Brunswick Power Corporation:企業の戦略的SWOT分析
    New Brunswick Power Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Ocular Therapeutix Inc (OCUL):企業の財務・戦略的SWOT分析
    Summary Ocular Therapeutix Inc (Ocular Therapeutix), formerly I-Therapeutix Inc, is a biopharmaceutical company that discovers, develops and commercializes therapies for treating eye diseases. The company’s lead product candidate DEXTENZA is used for the treatment of post-surgical ocular inflammatio …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆